SCHEMBL4254549

SCHEMBL4254549

CCCN(Cc1c(-c2ccc(C)cc2)nc2ccc(C)cn12)C(=O)c1ccc(C(F)(F)F)cc1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GABRB2 P47870 4/20 0.51
GABRA1 P14867 3/20 0.51
ALB P02768 2/20 0.51
OPRK1 P41145 2/20 0.51
KCNH2 Q12809 2/20 0.51
GABRA2 P47869 2/20 0.51
KDM4E B2RXH2 1/20 0.51
LMNA P02545 1/20 0.51
CYP3A4 P08684 1/20 0.51
CHRM1 P11229 1/20 0.51
HPGD P15428 1/20 0.51
GABRB1 P18505 1/20 0.51
GABRG2 P18507 1/20 0.51
GABRB3 P28472 1/20 0.51
GABRA3 P34903 1/20 0.51
ADRA1A P35348 1/20 0.51
HTR2B P41595 1/20 0.51
HSD17B10 Q99714 1/20 0.51
TSPO P30536 3/20 0.49
NR1I2 O75469 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4260602 0.92 GABRA1 (0.53) GABRB2GABRA1ALBOPRK1KCNH2
SCHEMBL4254710 0.87 GABRA1 (0.56) GABRB2GABRA1ALBOPRK1KCNH2
SCHEMBL14088719 0.87 GABRA1 (0.49) GABRB2GABRA1ALBOPRK1KCNH2
SCHEMBL4257273 0.87 GABRA1 (0.49) GABRB2GABRA1ALBOPRK1KCNH2
SCHEMBL4255844 0.79 GABRA1 (0.53) GABRB2GABRA1ALBOPRK1KCNH2
SCHEMBL4258956 0.78 GABRA1 (0.65) GABRB2GABRA1ALBOPRK1KCNH2
SCHEMBL13970091 0.77 GABRB2 (0.55) GABRB2GABRA1ALBOPRK1KCNH2
SCHEMBL1691682 0.77 GABRA1 (0.53) GABRB2GABRA1ALBOPRK1KCNH2
SCHEMBL9788663 0.77 GABRA1 (0.55) GABRB2GABRA1ALBOPRK1KCNH2
SCHEMBL4265947 0.75 GABRA1 (0.60) GABRB2GABRA1ALBOPRK1KCNH2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1814880-B1 IMIDAZO[1,2-A]PYRIDINE COMPOUNDS, COMPOSITIONS, USES AND METHODS RELATED THERETO FERRER INT (ES) 2009-01-28 EP disclosed
EP-1814880-B1 IMIDAZO[1,2-A]PYRIDINE COMPOUNDS, COMPOSITIONS, USES AND METHODS RELATED THERETO FERRER INT (ES) 2009-01-28 EP disclosed
US-20080200473-A1 Imidazo [1,2-a]Pyridine Compounds, Compositions, Uses and Methods Thereto FERRER INTERNACIONAL, S.A. (ES) 2008-08-21 US disclosed
US-20080200473-A1 Imidazo [1,2-a]Pyridine Compounds, Compositions, Uses and Methods Thereto FERRER INTERNACIONAL, S.A. (ES) 2008-08-21 US disclosed
EP-1814880-A1 IMIDAZO[1,2-A]PYRIDINE COMPOUNDS, COMPOSITIONS, USES AND METHODS RELATED THERETO FERRER INTERNACIONAL, S.A. (ES) 2007-08-08 EP disclosed
WO-2006051063-A1 IMIDAZO[1,2-A]PYRIDINE COMPOUNDS, COMPOSITIONS, USES AND METHODS RELATED THERETO FERRER INTERNACIONAL S. A. (ES) 2006-05-18 WO disclosed
WO-2006051063-A1 IMIDAZO[1,2-A]PYRIDINE COMPOUNDS, COMPOSITIONS, USES AND METHODS RELATED THERETO FERRER INTERNACIONAL S. A. (ES) 2006-05-18 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080200473-A1 Imidazo [1,2-a]Pyridine Compounds, Compositions, Uses and Methods Thereto GABRA1, GABRA2, GABRA3 GABRB2 5/4885GABRA1 1/4885ALB 4029/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.